Roivant Sciences Ltd. — Investor Relations & Filings
Roivant Sciences is a biopharmaceutical company that develops and commercializes medicines and technologies. The company operates a unique model by building agile, focused subsidiary companies known as 'Vants' to advance specific assets. This structure is designed to accelerate the discovery, development, and delivery of innovative treatments to patients through efficient capital allocation and execution. Roivant employs technology, including artificial intelligence for drug discovery and protein design, across its operations. The company's portfolio spans multiple therapeutic areas, such as autoimmune and pulmonary diseases, and includes commercial-stage products like Vtama for psoriasis and atopic dermatitis, alongside a broad pipeline of investigational drugs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Roivant Sciences Ltd. (0001635088) (Filer) | 2026-04-02 | English | |
| SCHEDULE 13G/A - Roivant Sciences Ltd. (0001635088) (Subject) | 2026-03-27 | English | |
| 4 - Roivant Sciences Ltd. (0001635088) (Issuer) | 2026-03-25 | English | |
| 4 - Roivant Sciences Ltd. (0001635088) (Issuer) | 2026-03-25 | English | |
| 8-K/A - Roivant Sciences Ltd. (0001635088) (Filer) | 2026-03-23 | English | |
| 4 - Roivant Sciences Ltd. (0001635088) (Issuer) | 2026-03-19 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOMM SA
Develops and manufactures biopharmaceuticals and biosimilar…
|
— | BR | Manufacturing |
|
BiomX Inc.
Clinical-stage company developing phage therapies to target…
|
PHGE | US | Manufacturing |
|
BIONEERCORPORATION
Develops and manufactures molecular biology products for re…
|
064550 | KR | Manufacturing |
|
BioNTech SE
Biotechnology company developing immunotherapies for cancer…
|
BNTX | DE | Manufacturing |
|
BioNxt Solutions Inc.
Clinical-stage developer of next-generation drug formulatio…
|
BNXT | CA | Manufacturing |
|
Biophage Pharma Inc.
Developing innovative phage-based therapies for antibiotic-…
|
BIPMF | CA | Manufacturing |
|
BioPorto
An in vitro diagnostics company specializing in biomarkers …
|
BIOPOR | DK | Manufacturing |
|
BIO-RAD LABORATORIES, INC.
Develops and manufactures products for life science and cli…
|
BIO | US | Manufacturing |
|
Biosergen AB
Develops drugs to treat severe and resistant invasive funga…
|
BIOSGN | SE | Manufacturing |
|
Biosino Bio-Technology and Science Incorporation
Major high-tech manufacturer of in-vitro diagnostic (IVD) p…
|
8247 | HK | Manufacturing |
Roivant Sciences Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30587/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30587 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30587 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30587 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30587}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Roivant Sciences Ltd. (id: 30587)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.